---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113085"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:28:52.196283+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharma gets Nasdaq bid-price extension to April 28, 2025

## Summary
- Nasdaq granted additional 180-day grace period until April 28, 2025 to regain $1.00 minimum bid price compliance.
- Company met all other Nasdaq Capital Market initial listing requirements; may effect reverse split if needed.
- If compliance not achieved by April 28, 2025, securities will be delisted, subject to appeal.

## SEC filing metadata
- accession: 0001104659-24-113085
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465924113085/0001104659-24-113085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465924113085/tm2427194d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113085
- JSON: https://secwatch.observer/filing/0001104659-24-113085.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.